Impact of empagliflozin add-on therapy on quality of life in patients of type 2 diabetes mellitus with hypertension: A prospective study

Conclusion: QoL is an essential measure with respect to patient-centered treatment approach. Empagliflozin, as an add-on medication, improved QoL, glycemic parameters and blood pressure in T2DM patients with hypertension. It can be recommended as an add-on, but more research with a larger sample size is required.

Source: Indian Journal of Public Health - November 11, 2022 Category: International Medicine & Public Health Authors: Imtiyaz Ahmed Najar Shariq Rashid Masoodi Shakeel Ahmed Mir Moomin Hussain Bhat Rakesh Raman Patyar Sazal Patyar Source Type: research